Research Article

Antibacterial and Antioxidant Efficacies of Secondary Metabolites from the Roots of Cyphostemma adenocaule: A Combined In Vitro and In Silico Study

Table 5

Molecular docking study of the isolated compounds (1–6) and ciprofloxacin against PK (S. aureus).

Compound/ligandBinding affinity (kcal/mol)H-bondResidual amino acid interactions
Hydrophobic/electrostaticVan der Waals

1−7.9Ala-337Lys-260 and Tyr-302Asp-303, Lys-260, Gln-338, Asp-339, and Lys-342
2−8.0Asp-303, salt bridge; attractive charge, Asn-29Arg-264, Lys-342, Tyr-302, Lys-260, and Asp-303
3−8.2Lys-260 and Asn-299Asp-303, Lys-260, and Leu-343Asp-339, Tyr-340, Lys-342, Gln-338, Asp-346, Arg-347, Asp-261, Arg-264, Tyr-302, Asp-303, and Tyr-302
4−8.3Thr-366 and Ala-358Ile-361 and His-365Thr-353, Asn-369, Ser-362, Thr-366, and Ala-358
5−8.7Lys-260, Arg-264, Asn-299, and Tyr-302Lys-260Asp-346, Ile-263, Asp-303, Asn-299, Tyr-302, Arg-347, Leu-343, Gln-338, Asp-339, and Lys-342
6−8.5Lys-260, Asp-339, Gln-338, Asn-299, and Asp-261Asp-303, Tyr-302, Lys-342, Leu-343, and Lys-260Asn-299, Asp-303, Tyr-302, and Arg-264
Ciprofloxacin−8.9Ser-362, Thr-366, and Asn-369His-365 and Ile-361Ala-358, Asn-369, Thr-348, Ile-361, and Met-467